FSSAI cracks down on Bengaluru firm over misbranded, expired infant food
Synopsis
Key Takeaways
The Food Safety and Standards Authority of India (FSSAI) on Thursday, 3 September launched strict enforcement action against British Lifesciences Private Limited, a food business operator based in Bengaluru, Karnataka, after inspections revealed misbranded and expired infant food products at its premises. The action forms part of a broader regulatory drive to ensure compliance in the infant food segment — one of the most safety-critical categories in the food supply chain.
What the Inspection Found
FSSAI officials conducted a targeted inspection of the firm's infant food stock and identified a substantial quantity of misbranded products — items whose labels did not meet prescribed regulatory standards. In addition, 3.7 metric tonnes of expired infant food articles were discovered, raising serious concerns about the firm's quality control and storage practices.
The misbranded stock was seized on the spot under the provisions of the Food Safety and Standards (FSS) Act, 2006. The expired inventory has been ordered to be destroyed under court directions, with the regulator confirming that the disposal was carried out safely to prevent the stock from being reused, diverted, or reintroduced into the food supply chain.
Legal Action Initiated
'Strict regulatory measures were taken against British Lifesciences Private Limited, Bengaluru, following food safety inspections of infant food products. Substantial quantity of misbranded infant food was seized. Legal proceedings have been initiated against the FBO,' FSSAI stated.
The regulator further noted: 'Considering the serious nature of the violations and the potential risk posed by non-compliant infant food products to infants and young children, appropriate legal proceedings were initiated against the FBO.' The exact nature of the legal charges has not yet been made public.
Why This Action Matters
Infant food products occupy a uniquely sensitive position in food safety regulation — they are consumed by the most vulnerable population group, and any lapse in labelling, composition, or shelf-life compliance can carry direct health consequences. Misbranded products create an additional layer of risk: caregivers and healthcare providers cannot make informed decisions when label information is inaccurate or misleading.
This enforcement action comes amid heightened regulatory scrutiny across India's packaged food sector, with FSSAI placing particular emphasis on infant formula, complementary foods, and nutrition supplements for young children. Notably, this is not an isolated incident — the regulator has stepped up market surveillance of infant food brands in recent months following consumer complaints and third-party audits flagging labelling inconsistencies.
FSSAI's Broader Enforcement Drive
The authority has underscored that the Bengaluru action is part of a sustained, nationwide enforcement campaign rather than a one-off raid. FSSAI said the drive reflects its commitment to ensuring that infant food available in the market meets all prescribed safety, quality, and labelling requirements under Indian food law.
Industry observers note that food business operators handling infant nutrition products are held to a stricter standard under the FSS Act, with penalties for violations significantly higher than those for general food categories. The outcome of legal proceedings against British Lifesciences Private Limited is expected to set a visible precedent for other manufacturers in the segment.